We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Articles

Results 1 to 5 of 6
Most popular |Most recent


FDA Clarifies Communication Rules for Medical Product Companies

USA - June 22 2018 On June 12, 2018, the U.S. Food and Drug Administration issued two key documents outlining the agency's current thinking regarding drug and device...

Emerson Siegle, Douglas Hallward-Driemeier, Gregory H. Levine, Albert F. Cacozza, Jr.

Outlook 2018 Teleconference: The Trump Administration’s Impact on Life Sciences and Health Carethe First Year

USA - January 23 2018 On Tuesday, January 23, Ropes & Gray hosted a teleconference on the regulatory and compliance impact of the Trump Administration’s first year on life...

Gregory H. Levine, Colleen A. Conry, Albert F. Cacozza, Jr, Thomas N. Bulleit.

Outlook 2017 Teleconference: Revisiting the Trump Administration’s Impact on Life Sciences and Health Carethe First 100 Days

USA - May 2 2017 On Tuesday, May 2, Ropes & Gray hosted a teleconference, “Outlook 2017 Teleconference: Revisiting the Trump Administration’s Impact on Life Sciences...

Gregory H. Levine, Colleen A. Conry, Albert F. Cacozza, Jr, Thomas N. Bulleit.

21st Century Cures Act

USA - December 13 2016 Hi, I'm Al Cacozza, a partner in the Washington, D.C. office of Ropes & Gray and a member of the firm's life sciences practice group. Today we will...

Gregory H. Levine, Albert F. Cacozza, Jr.

FDA issues revised draft reprints guidance

USA - March 4 2014 On February 28, 2014, the Food and Drug Administration ("FDA") released a revised draft guidance for industry entitled "Distributing Scientific and...

Gregory H. Levine, Alan Bennett, Albert F. Cacozza, Jr.